Trials and transparency
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has released a scathing report criticizing the medical procedures Parexel used in testing the TGN1412 drug. In-Pharma Technologist.com (“Parexcel back in hot water…“) reports that six individuals suffered severe side effects such as organ failure swelling of body parts due to poor administration of the trials…